WebbThe effect of anti-thymocyte globulin (ATG) on the outcome of hematopoietic stem cell transplantation (SCT) is dependent on formulation, dose and exposure. How WebbThe average total dose of basiliximab was 39.3±3.8 mg per patient (0.54±0.13 mg per kilogram). Rabbit antithymocyte globulin was initiated before reperfusion in 87.9% of all …
Antithymocyte Globulin Rabbit (Intravenous Route) - Mayo Clinic
Webb15 apr. 2009 · The most used commercial ATG preparation, Thymoglobulin (Genzyme Corporation, Cambridge, MA), is a purified polyclonal gamma globulin produced by immunizing rabbits with human thymocytes. Thymoglobulin has been noted to have consistent potency across all commercially available lots ( 4 ). Webb5 nov. 2024 · Thymoglobulin® and Grafalon® are 2 polyclonal rabbit anti-thymocyte globulin (ATG) used in allogeneic hematopoietic stem cell transplantation (allo-HSCT) to … oys27011
Thymoglobulin (anti-thymocyte globulin [rabbit]) - Sanofi
Webb29 sep. 2024 · Thymoglobulin® (Antithymocyte globulin [rabbit]) is used to treat or prevent rejection of kidney transplants. It can also be used to treat or prevent rejection of heart, … WebbAcute graft rejection remains a major problem in renal transplant recipients, and there is no consensus on the optimal immunosuppressive strategy. Immunoprophylaxis with Thymoglobulin® or basiliximab has significantly reduced the incidence of acute rejection episodes and graft loss following kidney transplantation. This open, randomized, … Webb15 okt. 2004 · Thymoglobulin administration was associated with some adverse events. Patient DIG102 had rash, fever, and wheezing, although these symptoms may have been related to a new onset adenoviral infection. The side effects resolved within 24 hours of the end of treatment. oysa founders cup